The structure and substrate specificity of human Cdk12/Cyclin K
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Phosphorylation of the RNA polymerase II C-terminal domain (CTD) by cyclin-dependent kinases is important for productive transcription. Here we determine the crystal structure of Cdk12/CycK and analyse its requirements for substrate recognition. Active Cdk12/CycK is arranged in an open conformation similar to that of Cdk9/CycT but different from those of cell cycle kinases. Cdk12 contains a C-terminal extension that folds onto the N- and C-terminal lobes thereby contacting the ATP ribose. The interaction is mediated by an HE motif followed by a polybasic cluster that is conserved in transcriptional CDKs. Cdk12/CycK showed the highest activity on a CTD substrate prephosphorylated at position Ser7, whereas the common Lys7 substitution was not recognized. Flavopiridol is most potent towards Cdk12 but was still 10-fold more potent towards Cdk9. T-loop phosphorylation of Cdk12 required coexpression with a Cdk-activating kinase. These results suggest the regulation of Pol II elongation by a relay of transcriptionally active CTD kinases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Cdk12 activity on the CTD requires Ser7 prephosphorylation. (a) Design of CTD substrate peptides used for kinetic and ESI-MS analyses. Peptides contained three consensus hepta-repeats with either no modification (cons. CTD[3]) or with phosphorylation marks continuously set at one residue of the heptad sequence as shown for Ser7 (pS7-CTD[3]). The same design principle was used for CTD peptides phosphorylated at Tyr1 (pY1-CTD[3]), Ser2 (pS2-CTD[3]), Thr4 (pT4-CTD[3]) and Ser5 (pS5-CTD[3]) or a peptide that contained a lysine at position 7 (K7-CTD[3]). (b) Activity of Cdk12/CycK for various CTD substrates. Of the seven peptides tested, Cdk12 showed the highest activity for continuous Ser7 prephosphorylation. Minor activities were detected for Ser2 and Thr4 prephosphorylated peptides. Remarkably, no activity was seen for cons. CTD[3] or the K7-peptide, which is in contrast to P-TEFb. In addition, Cdk12 exhibited no activity on the pSer5 peptide. (c) ESI-MS analyses of CTD peptides before and after 4 h of incubation with 2 μM Cdk12/CycK. Whereas no phosphorylation occurred for the consensus peptide, the pS7-CTD[3] substrate got readily phosphorylated up to three times. (d) Time course of Cdk12/CycK mediated CTD phosphorylation. The prephosphorylated Ser7 peptide got phosphorylated over time to saturation, while the non-phosphorylated peptide showed low susceptibility as a Cdk12 substrate. Data in panels b and d are the mean±s.d. of three independent experiments.](https://figures.cochat.ai/paper-figures/10d663b65180482a83bae3bf104eeec2/the-structure-and-substrate-specificity-of-human-cdk12-cyclin-k-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CR8 is a pleiotropic CDK inhibitor reported to bind CDK1/2/3/5/7/9/126,19”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, we identified cyclin-dependent kinase 12 (CDK12), which is a known target of CR819 and whose activity depends on the interaction with cycK20, as a crucial component for CR8-induced cycKeGFP destabilisation (Fig. 1g, Extended Data Fig. 2h–k).”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CDK12 and CDK13 are two structurally similar kinases that has the ability to phosphorylate serine 2 of the POLII CTD heptad repeats (Bösken et al., 2014; Dixon-Clarke et al., 2015; Greifenberg et al., 2016).”
From Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation (2020) · cites this paper as Bösken et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The density for this region could only be tentatively assigned, likely due to the presence of multiple conformations, but the CDK12 C-terminal tail clearly engages with DDB1 and assumes a conformation different from those seen in isolated CDK12-cycK structures (Extended Data Fig. 6a, b, d)19,21.”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Transcriptional Regulation and Its Misregulation in Disease
Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,620
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
Progression through the RNA Polymerase II CTD Cycle
Buratowski, S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.019 · Cited by 772
Phosphorylation and functions of the RNA polymerase II CTD
Phatnani, H. P., & Greenleaf, A. L. (2006) · Genes & Development · doi:10.1101/gad.1477006 · Cited by 752 · cited 7×
“However, the phosphorylation activity was less than one-third of that towards the uniformly phosphorylated pS7CTD[3] substrate.”
BackgroundMethodInfluentialKinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Structural basis of cyclin-dependent kinase activation by phosphorylation
Russo, A. A., Jeffrey, P. D., & Pavletich, N. P. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-696 · Cited by 598
Defining mechanisms that regulate RNA polymerase II transcription in vivo
Fuda, N. J., Ardehali, M. B., & Lis, J. T. (2009) · Nature · doi:10.1038/nature08449 · Cited by 576
Brown, N. R., Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (1999) · Nature Cell Biology · doi:10.1038/15674 · Cited by 546
Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M. (2011) · Genes & Development · doi:10.1101/gad.16962311 · Cited by 522
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Program, N. C. S., Wei, X., Walia, V., Lin, J. C., Teer, J. K., Prickett, T. D., Gartner, J., Davis, S., Stemke-Hale, K., Davies, M. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.810 · Cited by 471
The RNA Polymerase II Carboxy-Terminal Domain (CTD) Code
Eick, D., & Geyer, M. (2013) · Chemical Reviews · doi:10.1021/cr400071f · Cited by 470
Self-citationUniform transitions of the general RNA polymerase II transcription complex
Mayer, A., Lidschreiber, M., Siebert, M., Leike, K., Söding, J., & Cramer, P. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1903 · Cited by 445
The Structural Basis for Control of Eukaryotic Protein Kinases
Endicott, J. A., Noble, M. E. M., & Johnson, L. N. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052410-090317 · Cited by 427
CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1
Bartkowiak, B., Liu, P., Phatnani, H. P., Fuda, N. J., Cooper, J. J., Price, D. H., Adelman, K., Lis, J. T., & Greenleaf, A. L. (2010) · Genes & Development · doi:10.1101/gad.1968210 · Cited by 400
Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
Larochelle, S., Amat, R., Glover-Cutter, K., Sansó, M., Zhang, C., Allen, J. J., Shokat, K. M., Bentley, D. L., & Fisher, R. P. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2399 · Cited by 390
Self-citationBaumli, S., Lolli, G., Lowe, E. D., Troiani, S., Rusconi, L., Bullock, A. N., Debreczeni, J. É., Knapp, S., & Johnson, L. N. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.121 · Cited by 353
Glover-Cutter, K., Larochelle, S., Erickson, B., Zhang, C., Shokat, K., Fisher, R. P., & Bentley, D. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00637-09 · Cited by 350
Self-citationBuratowski, S. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb0903-679 · Cited by 334
Structural Basis for the Autoinhibition of Calcium/Calmodulin-Dependent Protein Kinase I
Goldberg, J., Nairn, A. C., & Kuriyan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81066-1 · Cited by 326
Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7
Chapman, R. D., Heidemann, M., Albert, T. K., Mailhammer, R., Flatley, A., Meisterernst, M., Kremmer, E., & Eick, D. (2007) · Science · doi:10.1126/science.1145977 · Cited by 323
Self-citationTFIIH Kinase Places Bivalent Marks on the Carboxy-Terminal Domain of RNA Polymerase II
Akhtar, M. S., Heidemann, M., Tietjen, J. R., Zhang, D. W., Chapman, R. D., Eick, D., & Ansari, A. Z. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.016 · Cited by 308
Self-citationDynamic phosphorylation patterns of RNA polymerase II CTD during transcription
Heidemann, M., Hintermair, C., Voß, K., & Eick, D. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.08.013 · Cited by 299
Self-citationCTD Tyrosine Phosphorylation Impairs Termination Factor Recruitment to RNA Polymerase II
Mayer, A., Heidemann, M., Lidschreiber, M., Schreieck, A., Sun, M., Hintermair, C., Kremmer, E., Eick, D., & Cramer, P. (2012) · Science · doi:10.1126/science.1219651 · Cited by 257
Self-citationGene-specific RNA polymerase II phosphorylation and the CTD code
Kim, H., Erickson, B., Luo, W., Seward, D., Graber, J. H., Pollock, D. D., Megee, P. C., & Bentley, D. L. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1913 · Cited by 235
WANG, S., & FISCHER, P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.003 · Cited by 232
The C-Terminal Domain of RNA Polymerase II Is Modified by Site-Specific Methylation
Sims, R. J., Rojas, L. A., Beck, D., Bonasio, R., Schüller, R., Drury, W. J., Eick, D., & Reinberg, D. (2011) · Science · doi:10.1126/science.1202663 · Cited by 226
Self-citationBataille, A. R., Jeronimo, C., Jacques, P.-É., Laramée, L., Fortin, M.-È., Forest, A., Bergeron, M., Hanes, S. D., & Robert, F. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.024 · Cited by 220
MultiBac: expanding the research toolbox for multiprotein complexes
Bieniossek, C., Imasaki, T., Takagi, Y., & Berger, I. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.005 · Cited by 216
Madhusudan, Akamine, P., Xuong, N.-H., & Taylor, S. S. (2002) · Nature Structural Biology · doi:10.1038/nsb780 · Cited by 209
Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition
Czudnochowski, N., Bösken, C. A., & Geyer, M. (2012) · Nature Communications · doi:10.1038/ncomms1846 · Cited by 193
Self-citationUpdating the RNA polymerase CTD code: adding gene-specific layers
Egloff, S., Dienstbier, M., & Murphy, S. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.03.007 · Cited by 177
RNA Polymerase II C-Terminal Domain: Tethering Transcription to Transcript and Template
Corden, J. L. (2013) · Chemical Reviews · doi:10.1021/cr400158h · Cited by 175
Qiu, H., Hu, C., & Hinnebusch, A. G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.018 · Cited by 172
Hintermair, C., Heidemann, M., Koch, F., Descostes, N., Gut, M., Gut, I., Fenouil, R., Ferrier, P., Flatley, A., Kremmer, E., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.123 · Cited by 161
Self-citationPhosphorylation of the Yeast Rpb1 C-terminal Domain at Serines 2, 5, and 7
Kim, M., Suh, H., Cho, E.-J., & Buratowski, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028993 · Cited by 149
Chemical-genomic dissection of the CTD code
Tietjen, J. R., Zhang, D. W., Rodríguez-Molina, J. B., White, B. E., Akhtar, M. S., Heidemann, M., Li, X., Chapman, R. D., Shokat, K., Keles, S., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1900 · Cited by 148
Self-citationViladevall, L., Amour, C. V. S., Rosebrock, A. P., Schneider, S., Zhang, C., Allen, J. J., Shokat, K. M., Schwer, B., Leatherwood, J., & Fisher, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.029 · Cited by 138
Self-citationDeciphering the RNA Polymerase II CTD Code in Fission Yeast
Schwer, B., & Shuman, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.024 · Cited by 135
In vivo live imaging of RNA polymerase II transcription factories in primary cells
Ghamari, A., van de Corput, M. P. C., Thongjuea, S., van Cappellen, W. A., van IJcken, W., van Haren, J., Soler, E., Eick, D., Lenhard, B., & Grosveld, F. G. (2013) · Genes & Development · doi:10.1101/gad.216200.113 · Cited by 131
Self-citationIntegrated genomic analyses of ovarian carcinoma
The Cancer Genome Atlas Research Network (2011) · Nature · doi:10.1038/nature10166 · Cited by 129
Cheng, S.-W. G., Kuzyk, M. A., Moradian, A., Ichu, T.-A., Chang, V. C.-D., Tien, J. F., Vollett, S. E., Griffith, M., Marra, M. A., & Morin, G. B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06267-11 · Cited by 124
Schröder, S., Herker, E., Itzen, F., He, D., Thomas, S., Gilchrist, D. A., Kaehlcke, K., Cho, S., Pollard, K. S., Capra, J. A., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.009 · Cited by 115
Self-citationBao, Z. Q., Jacobsen, D. M., & Young, M. A. (2011) · Structure · doi:10.1016/j.str.2011.02.016 · Cited by 103
Structural insights into the Cyclin T1–Tat–TAR RNA transcription activation complex from EIAV
Anand, K., Schulte, A., Vogel‐Bachmayr, K., Scheffzek, K., & Geyer, M. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1513 · Cited by 82
Self-citationPol II CTD kinases Bur1 and Kin28 promote Spt5 CTR‐independent recruitment of Paf1 complex
Qiu, H., Hu, C., Gaur, N. A., & Hinnebusch, A. G. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.188 · Cited by 82
The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat
Schulze-Gahmen, U., Upton, H., Birnberg, A., Bao, K., Chou, S., Krogan, N. J., Zhou, Q., & Alber, T. (2013) · eLife · doi:10.7554/elife.00327 · Cited by 79
Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb
Dames, S. A., Schönichen, A., Schulte, A., Barborič, M., Peterlin, B. M., Grzesiek, S., & Geyer, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701848104 · Cited by 69
Self-citationPhosphorylation of RNAPII: To P-TEFb or not to P-TEFb?
Bartkowiak, B., & Greenleaf, A. L. (2011) · Transcription · doi:10.4161/trns.2.3.15004 · Cited by 62
Amour, C. V. S., Sansó, M., Bösken, C. A., Lee, K. M., Larochelle, S., Zhang, C., Shokat, K. M., Geyer, M., & Fisher, R. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06657-11 · Cited by 52
Self-citationThe CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b
Baumli, S., Hole, A. J., Wang, L.-Z., Noble, M. E. M., & Endicott, J. A. (2012) · Structure · doi:10.1016/j.str.2012.08.011 · Cited by 38
Crystal Structure of Human Cyclin K, a Positive Regulator of Cyclin-dependent Kinase 9
Baek, K., Brown, R. S., Birrane, G., & Ladias, J. A. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.057 · Cited by 28
The Rise of Oxygen and Aerobic Biochemistry
Saito, M. A. (2012) · Structure · doi:10.1016/j.str.2011.12.006 · Cited by 19
Cited by
The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain
Harlen, K. M., & Churchman, L. S. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.10 · Cited by 499
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.019 · Cited by 439
“Both Flavopiridol and THZ1 have been shown to cross react with CDK12/13 at higher concentrations (Bosken et al., 2014; Kwiatkowski et al., 2014), therefore this shared pharmacology may also impact the transcriptional and phenotypic response of SCLC to these inhibitors.”
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Słabicki, M., Kozicka, Z., Petzold, G., Li, Y.-D., Manojkumar, M., Bunker, R. D., Donovan, K. A., Sievers, Q. L., Koeppel, J., Suchyta, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2374-x · Cited by 433
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Whittaker, S. R., Mallinger, A., Workman, P., & Clarke, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.008 · Cited by 384
“However, knockout or chemical inhibition experiments have had, at best, modest effects on global CTD phosphorylation, which can be interpreted as CDK12 either having no importance in human CTD Ser2 phosphorylation or having functional redundancy with CDK13 or other Ser2 kinases (Bosken et al., 2014; Bartkowiak, Yan, &…”
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
Zhang, T., Kwiatkowski, N., Olson, C. M., Dixon-Clarke, S. E., Abraham, B. J., Greifenberg, A. K., Ficarro, S. B., Elkins, J. M., Liang, Y., Hannett, N. M., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2166 · Cited by 374
Self-citation
Metadata
- Authors
- Bösken, C. A., Farnung, L., Hintermair, C., Merzel Schachter, M., Vogel-Bachmayr, K., Blazek, D., Anand, K., Fisher, R. P., Eick, D., & Geyer, M.
- Affiliations
- Center of Advanced European Studies and Research (DE)
- Max Planck Institute of Molecular Physiology (DE)
- Center for Integrated Protein Science Munich (DE)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Geyer, Matthias
- Venue
- Nature Communications
- Published
- 2014-03-24
- Volume
- 5
- Issue
- 1
- Pages
- 3505-3505
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3973122
- OpenAlex
- W2074045994
- Semantic Scholar
- 7f2f1f4958b1ced0a261be63f6b87c33e72321b5
- Cited by
- 191
- References
- 60
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 19 · 2020: 21 · 2019: 12 · 2018: 7 · 2017: 14 · 2016: 13 · 2015: 13 · 2014: 9
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- Max Planck Digital Library (submittedVersion, other-oa)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 684, SFB/TR 5)
- Grantová Agentura České Republiky (CZ.1.05/1.1.00/02.0068, GA14-09979S)
- Central European Institute of Technology (CZ.1.05/1.1.00/02.0068., CZ.1.05/1.1.00/02)
- International Max Planck Research School for Advanced Methods in Process and Systems Engineering
- National Institutes of Health
- National Cancer Institute (T32-CA78207, T32CA078207)
- National Institute of General Medical Sciences (GM104291, R01GM104291)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- CDK12, cyclin K, cyclin-dependent kinases, RNA polymerase II C-terminal domain, CTD phosphorylation, substrate specificity, crystal structure, flavopiridol, T-loop phosphorylation, CDK-activating kinase, transcription elongation
- MeSH terms
- Crystallization, Enzyme-Linked Immunosorbent Assay, HeLa Cells, Humans, Models, Molecular, Protein Conformation, Mass Spectrometry, Substrate Specificity, Blotting, Western, Cyclins, Cyclin-Dependent Kinases, Multiprotein Complexes, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.